Home › Funds › Comprehensive Financial Management LLC › RXRX

Comprehensive Financial Management LLC position in RXRX

RECURSION PHARMACEUTICALCLASS A · Health Care

Comprehensive Financial Management LLC reported holding 941,895 shares of RXRX (RECURSION PHARMACEUTICALCLASS A) in its Q2 2026 13F filing — a position valued at US$3.5M, representing 0.11% of its reported portfolio and ranking #22 among its reported holdings. Comprehensive Financial Management LLC has disclosed RXRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)941.89K sh
Reported value held$3.46M
Portfolio Weight0.11%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Comprehensive Financial Management LLC's RXRX position evolved

Comprehensive Financial Management LLC first disclosed a stake in RXRX in Q3 2023 at 941,895 shares (US$7.2M). The position peaked in Q1 2024 at 941,895 shares, worth US$9.4M. Across 12 filings, Comprehensive Financial Management LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 941,895 shares valued at US$3.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 941.89K $7.21M New
Q4 2023 941.89K $9.29M Hold
Q1 2024 941.89K $9.39M Hold
Q2 2024 941.89K $7.06M Hold
Q3 2024 941.89K $6.21M Hold
Q4 2024 941.89K $6.37M Hold
Q1 2025 941.89K $4.98M Hold
Q2 2025 941.89K $4.77M Hold
Q3 2025 941.89K $4.60M Hold
Q4 2025 941.89K $3.85M Hold
Q1 2026 941.89K $2.89M Hold
Q2 2026 941.89K $3.46M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RXRX and 13F data

RXRX (RECURSION PHARMACEUTICALCLASS A) is a Health Care company. 29 other funds we track also report a position in RXRX — the largest reported positions include ARK Invest (US$151.7M), SOFTBANK GROUP CORP. (US$50.0M), MIC Capital Management UK LLP (US$35.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RXRX

All RXRX fund holders →

FAQ

How long has Comprehensive Financial Management LLC held RXRX?

Comprehensive Financial Management LLC has disclosed RXRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Comprehensive Financial Management LLC's current position in RXRX?

As of Q2 2026, Comprehensive Financial Management LLC holds 941.89K shares of RXRX (RECURSION PHARMACEUTICALCLASS A), valued at $3.46M, representing 0.11% of its reported portfolio and ranking #22.

Has Comprehensive Financial Management LLC been buying or selling RXRX?

In the latest 13F filing (Q2 2026), Comprehensive Financial Management LLC held unchanged its position in RXRX. The position peaked in Q1 2024 at 941.89K shares.

Which other funds hold RXRX?

Other major institutional holders of RXRX include ARK Invest, SOFTBANK GROUP CORP., MIC Capital Management UK LLP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.